Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation

Tissue Antigens

Volumn 52, Issue 5, 1998, Pages 435-443

  Cotler, S J ^a,c   Gaur, L K ^b   Gretch, D R ^a   Wile, M ^a,d   Strong, D M ^b   Bronner, M P ^a   Carithers Jr , R L ^b   Emond, M J ^a   Perkins, J D ^a   Nelson, K A ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d MONMOUTH MEDICAL CENTER   (United States)

Author keywords

DQB1; DRB1; HCV; Liver transplantation; PCR SSOP; Serology

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CYTOPATHOGENIC EFFECT; DISEASE COURSE; FEMALE; HEPATITIS C; HLA MATCHING; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER INJURY; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS; VIREMIA;

HEPATITIS C VIRUS;

EID: 7844219849     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03070.x     Document Type: Article

References (44)

1. Wright TL, Donegan E, Hsu HH et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992: 103: 317-22.
2. Gang EJ, Naoumov NV, Qian KP et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996: 110: 167-77.
3. Gretch DR, Bacchi CE, Corey L et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995: 22: 1-9.
4. Feray C, Gigou M, Samuel D et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994: 20: 1137-13.
5. Casavilla A, Mateo R, Rakela J et al. Impact of hepatitis C virus (HCV) infection on survival following primary liver transplantation (OLTX) under FK506. Hepatology 1994: 20: 133A.
6. Gane EJ, Portmann BC, Naoumov NV et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996: 334: 815-20.
7. Villa E, Grottola A, Buttafoco P et al. Long-term follow-up of hepatitis C virus (HCV) infection in liver transplant patients. Clin Transplant 1995: 9: 160-4.
8. Gretch DR, Polvak SJ, Wilson JJ et al. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996: 70: 7622-31.
9. Markus BH, Duquesnoy RJ, Gordon RD et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988: 46: 372-7.
10. Manez R, Mateo R, Tabasco J et al. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995: 59: 640-2.
11. Gretch D, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992: 30: 2145-9.
12. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-9.
13. Nikaein A, ed. American Society for Histocompatibility and Immunogenetics laboratory manual. 3rd ed. Lenexa, 1995.
14. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991: 33: 163-70.
15. Leech NJ, Kitabchi AE, Gaur LK et al. Genetic and immunological markers of insulin dependent diabetes in Black Americans. Autoimmunity 1995: 22: 27-32.
16. Ferrell LD, Wright TL, Roberts J et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992: 16: 865-76.
17. Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995: 76: 1197-204.
18. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993: 74: 2391-9.
19. Hiramatsu N, Hayashi N, Haruna Y et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 1992: 16: 306-11.
20. Kao J, Lai M, Chen V et al. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis. Am J Gastroenterol 1996: 91: 506-10.
21. Gretch D, Wile M, Gaur L et al. Donor-recipient match at the HLA-DQB locus is associated with recrudescence of chronic hepatitis following liver transplantation for end stage hepatitis C. Hepatology 1993: 18: 108A.
22. Brandhagen DJ, Czaja AJ, Gordon FD et al. A comparison of human leukocyte antigen alleles in liver transplanted versus nontransplanted patients with hepatitis C virus. Gastroenterology 1996: 110: A1157.
23. Missale G, Brems JJ, Takiff H et al. Human leukocyte antigen class I-independent pathways may contribute to hepatitis B virus-induced liver disease after liver transplantation. Hepatology 1993: 18: 491-6.
24. Gilles PN, Guerrette DL, Ulevitch RJ et al. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma. Hepatology 1992: 16: 655-03.
25. Toyonaga T, Hino O, Sugai S et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A 1994: 91: 614-8.
26. Paulnock DM. Macrophage activation by T cells. Curr Opin Immunol 1992: 4: 344-9.
27. Bouffard P, Hayashi PH, Acevedo R et al. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992: 166: 1276-80.
28. Davis CL, Gretch DR, Perkins JD et al. Hepatitis C-associated glomerular disease in liver transplant recipients. Liver Transpl Surg 1995: 1: 166-75.
29. Gournay J, Ferrell LD, Roberts JP et al. Cryoglobulinemia presenting after liver transplantation. Gastroenterology 1996: 110: 265-70.
30. Woitas RP, Lechmann M, Jung G et al. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997: 159: 1012-8.
31. Koziel MJ, Dudley D, Wong JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis [published erratum appears in Immunol 1993: 150: 2563]. J Immunol 1992: 149: 3339-44.
32. Koziel MJ, Dudley D, Afdhal N et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995: 96: 2311-21.
33. Koziel MJ, Dudley D, Afdhal N et al. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993: 67: 7522-32.
34. Ballardini G, Groff P, Pontisso P et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995: 95: 2067-75.
35. Fiore G, Angarano I, Caccetta L et al. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroenterol Hepatol 1997: 9: 491-6.
36. Ando K, Hiroishi K, Kaneko T et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997: 158: 5283-91.
37. Pozzato G, Kaneko S, Moretti M et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994: 43: 291-6.
38. Nousbaum JB, Pol S, Nalpas B et al. Hepatitis C virus type 1b (H) infection in France and Italy. Collaborative Study Group. Ann Intern Med 1995: 122: 161-8.
39. Feray C, Gigou M, Samuel D et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation, Gastroenterology 1995: 108: 1088-96.
40. Zhou S, Kim M, Ferrell L, Wright TL. HCV genotyping of liver transplant (OLT) recipients: relation to viremia and histology. Hepatology 1994: 20: 134A.
41. Di Martino V, Saurini F, Samuel D et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997: 26: 1343-50.
42. O'Grady JG, Alexander GJ, Sutherland S et al. Cytomegalovirus infection and donor recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988: 2: 302-5.
43. Sheiner PA, Schwartz ME, Mor E et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995: 21: 30-4.
44. Rosen HR, Martin P, Shackleton CR, Farmer DA, Holt C, Busuttil RW. OKT3 use associated with diminished graft and patient survival in patients transplanted for chronic hepatitis C. Hepatology 1995: 22: 132A.